文献速递癫痫认知障碍与痴呆

儿童期起病癫痫合并智力障碍成人致病性拷贝数变异患病率

Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability.
PubMed 文献 · JAMA Neurol · 2017-01-01

该横断面研究纳入143例儿童期起病、成年仍有癫痫发作且伴智力障碍、无结构性脑异常或代谢病因的成人,用全基因组微阵列筛查致病性拷贝数变异(CNV)。23例先证者(16.1%)及4例受累亲属(2.8%)携带致病或可能致病CNV,提示成人不明原因儿童期起病癫痫合并智力障碍者应行微阵列分析。

要点

  • 成人儿童期起病癫痫合并智力障碍者致病性CNV检出率较高,应考虑微阵列分析。
  • 部分CNV为新发(47.8%),也有父源或母源遗传(17.4%)。
  • ABAT重复与Lennox-Gastaut综合征、KIAA2022缺失与Jeavons综合征相关。

核心结论

  • 儿童期起病癫痫合并智力障碍的成人中致病性或可能致病性CNV患病率较高,支持对该人群进行微阵列分析。

研究设计与样本

  • 横断面研究,2012年1月1日至2014年12月31日从Toronto Western Hospital癫痫门诊招募143例先证者,行全基因组微阵列检测,按美国医学遗传学与基因组学学会指南判定CNV致病性。

主要发现

  • 23例先证者(16.1%)和4例受累亲属(2.8%)携带致病或可能致病CNV(0.08-18.9 Mb)。
  • 23例阳性先证者中5例(21.7%)报告超过1个CNV;父母检测显示11例(47.8%)为新发CNV,4例(17.4%)为遗传自父母。
  • 23例阳性先证者中16例(69.6%)存在既往已记录的人类遗传病和/或癫痫相关CNV热点。
  • 发现8个非复发性罕见CNV重叠智力障碍、孤独症和/或癫痫相关基因:2p16.1-p15重复、6p25.3-p25.1重复、8p23.3p23.1缺失、9p24.3-p23缺失、10q11.22-q11.23重复、12p13.33-13.2重复、13q34缺失、16p13.2重复。
  • ABAT、KIAA2022、COL4A1、CACNA1C、SMARCA2五个基因因潜在致病性及对变异耐受性低而受关注;ABAT重复与Lennox-Gastaut综合征相关,KIAA2022缺失与Jeavons综合征相关。

关键数值与推荐

  • 致病性CNV判定依据美国医学遗传学与基因组学学会指南,并以Residual Variation Intolerance Score评估CNV内基因与表型的可能关系。
  • 纳入标准为儿童期癫痫起病且成年仍有发作、任何程度智力障碍、无可用以解释癫痫的结构性脑异常或代谢性疾病。

临床怎么用

  • 对不明原因儿童期起病癫痫合并智力障碍的成人,可考虑全基因组微阵列检测以发现致病性CNV。
  • 检出CNV后应结合父母检测判断新发或遗传,并关注ABAT、KIAA2022等候选基因与特定癫痫综合征的关联。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Copy number variation (CNV) is an important cause of neuropsychiatric disorders. Little is known about the role of CNV in adults with epilepsy and intellectual disability. OBJECTIVES: To evaluate the prevalence of pathogenic CNVs and identify possible candidate CNVs and genes in patients with epilepsy and intellectual disability. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, genome-wide microarray was used to evaluate a cohort of 143 adults with unexplained childhood-onset epilepsy and intellectual disability who were recruited from the Toronto Western Hospital epilepsy outpatient clinic from January 1, 2012, through December 31, 2014. The inclusion criteria were (1) pediatric seizure onset with ongoing seizure activity in adulthood, (2) intellectual disability of any degree, and (3) no structural brain abnormalities or metabolic conditions that could explain the seizures. MAIN OUTCOMES AND MEASURES: DNA screening was performed using genome-wide microarray platforms. Pathogenicity of CNVs was assessed based on the American College of Medical Genetics guidelines. The Residual Variation Intolerance Score was used to evaluate genes within the identified CNVs that could play a role in each patient's phenotype. RESULTS: Of the 2335 patients, 143 probands were investigated (mean [SD] age, 24.6 [10.8] years; 69 male and 74 female). Twenty-three probands (16.1%) and 4 affected relatives (2.8%) (mean [SD] age, 24.1 [6.1] years; 11 male and 16 female) presented with pathogenic or likely pathogenic CNVs (0.08-18.9 Mb). Five of the 23 probands with positive results (21.7%) had more than 1 CNV reported. Parental testing revealed de novo CNVs in 11 (47.8%), with CNVs inherited from a parent in 4 probands (17.4%). Sixteen of 23 probands (69.6%) presented with previously cataloged human genetic disorders and/or defined CNV hot spots in epilepsy. Eight nonrecurrent rare CNVs that overlapped 1 or more genes associated with intellectual disability, autism, and/or epilepsy were identified: 2p16.1-p15 duplication, 6p25.3-p25.1 duplication, 8p23.3p23.1 deletion, 9p24.3-p23 deletion, 10q11.22-q11.23 duplication, 12p13.33-13.2 duplication, 13q34 deletion, and 16p13.2 duplication. Five genes are of particular interest given their potential pathogenicity in the corresponding phenotypes and least tolerability to variation: ABAT, KIAA2022, COL4A1, CACNA1C, and SMARCA2. ABAT duplication was associated with Lennox-Gastaut syndrome and KIAA2022 deletion with Jeavons syndrome. CONCLUSIONS AND RELEVANCE: The high prevalence of pathogenic CNVs in this study highlights the importance of microarray analysis in adults with unexplained childhood-onset epilepsy and intellectual disability. Additional studies and comparison with similar cases are required to evaluate the effects of deletions and duplications that overlap specific genes.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Borlot F, Regan BM, Bassett AS, et al. Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability. JAMA Neurol. 2017. PMID: 28846756. doi:10.1001/jamaneurol.2017.1775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。